Sputnik V Covid Vaccine

There has been a study in Russia regarding the Sputnik V vaccine developed against Covid-19, in which its single dose has been described as very effective.

Sputnik V Covid-19 Vaccine Study

A single dose of anti-Covid-19 vaccine 'Sputnik-V' can create more immunity against SARS-CoV-2.  This has been revealed in a study.  COVID-19 is caused by SARS-CoV-2 virus (Study on Sputnik V Vaccine). Earlier in a study, it was revealed that two doses of 'Sputnik-V' create 92 percent immunity against Kovid-19.  'Sputnik-V' has been made by mixing two 'adenoviruses'.

 These are viruses that cause many diseases including cold, fever and sore throat (Sputnik V Vaccine Efficacy). A new study, published Tuesday in the journal Cell Reports Medicine, sought to find out whether a single dose of the vaccine could provide more public health benefits than two doses, allowing large populations to be treated as quickly as possible.  

Urgent need to compile data

Andrea Gamarnik of the Fundación Instituto Leloir-Coniquet in Buenos Aires, Argentina, senior author of this study, said, "Due to limited vaccine supply and uneven vaccine distribution in many regions of the world, health officials need to consider vaccination strategies."There is an urgent need to compile data related to the immunity of the vaccine in order to optimize it.

 Study done on 289 health workers

"The peer-reviewed data we present provide information to guide public health decisions in the current global health emergency," he said. The researchers used one dose and two doses of 'Sputnik-V' on 289 healthcare workers in the new study. After taking the first dose, 94 percent of these participants developed 'immunoglobulin G (IGG) antibodies' against the virus and 90 percent showed evidence of neutralizing 'antibodies', which affect the ability of the virus to infect cells.  

 Study that revealed

The research found that already infected participants had significantly higher levels of IgG and 'neutralizing antibodies' after a single dose than those who did not get the infection. At the same time, the second dose did not increase the production of neutralizing 'antibodies' in already infected (Results of Sputnik V Vaccine Study). He said that the high level of immunity to these people after one dose, suggests the administration to delay the second dose, so that more and more people can get the vaccine as soon as possible.

Read more :- Henry Ford Biography

Read more:- Success Story of Cadbury Chocolate

Read more : - Congo River Facts